Lipid metabolic enzymes: emerging drug targets for the treatment of obesity.
about
ACC2 is expressed at high levels in human white adipose and has an isoform with a novel N-terminus [corrected]Molecular identification of microsomal acyl-CoA:glycerol-3-phosphate acyltransferase, a key enzyme in de novo triacylglycerol synthesisThe blind men 'see' the elephant-the many faces of fatty liver diseaseOrganophosphate-sensitive lipases modulate brain lysophospholipids, ether lipids and endocannabinoidsRegulation of adipocyte autophagy--the potential anti-obesity mechanism of high density lipoprotein and ApolipoproteinA-IThe pharmacological landscape and therapeutic potential of serine hydrolasesInhibitors of pancreatic lipase: state of the art and clinical perspectivesLiposomal delivery systems for intestinal lymphatic drug transportMarine Algae as a Potential Source for Anti-Obesity AgentsCharacterization of human SCD2, an oligomeric desaturase with improved stability and enzyme activity by cross-linking in intact cellsIn silico identification of potent pancreatic triacylglycerol lipase inhibitors from traditional Chinese medicineHydrogen sulfide promotes adipogenesis in 3T3L1 cellsDiacylglycerol acyltransferase-1 inhibition enhances intestinal fatty acid oxidation and reduces energy intake in ratsResistance to diet-induced obesity and associated metabolic perturbations in haploinsufficient monocarboxylate transporter 1 miceAnti-obesity action of gingerol: effect on lipid profile, insulin, leptin, amylase and lipase in male obese rats induced by a high-fat diet.Hepatic Monoacylglycerol O-acyltransferase 1 as a Promising Therapeutic Target for Steatosis, Obesity, and Type 2 Diabetes.Monoacylglycerol acyltransferase-2 is a tetrameric enzyme that selectively heterodimerizes with diacylglycerol acyltransferase-1.Genetic control of de novo lipogenesis: role in diet-induced obesityReishiMax, mushroom based dietary supplement, inhibits adipocyte differentiation, stimulates glucose uptake and activates AMPK.Rab32 is important for autophagy and lipid storage in Drosophila.Estrogen receptor-{beta}-selective ligands alleviate high-fat diet- and ovariectomy-induced obesity in mice.Targeting metastasis-initiating cells through the fatty acid receptor CD36.The role of lipid and carbohydrate digestive enzyme inhibitors in the management of obesity: a review of current and emerging therapeutic agentsComparative genomics and functional study of lipid metabolic genes in Caenorhabditis elegans.Acyl protein thioesterase inhibitors as probes of dynamic S-palmitoylation.Lipoprotein lipase, tissue expression and effects on genes related to fatty acid synthesis in goat mammary epithelial cells.The use of stable-isotopically labeled oleic acid to interrogate lipid assembly in vivo: assessing pharmacological effects in preclinical speciesmTOR complex 2 in adipose tissue negatively controls whole-body growthExtracts of Rhizoma polygonati odorati prevent high-fat diet-induced metabolic disorders in C57BL/6 mice.New insight into the molecular drug target of diabetic nephropathy.Efficacy of massage therapy on pain and dysfunction in patients with neck pain: a systematic review and meta-analysis.The nuclear receptor DAF-12 regulates nutrient metabolism and reproductive growth in nematodes.Food intake regulates oleoylethanolamide formation and degradation in the proximal small intestineBoesenbergia pandurata attenuates diet-induced obesity by activating AMP-activated protein kinase and regulating lipid metabolism.Associations of Body Composition Measurements with Serum Lipid, Glucose and Insulin Profile: A Chinese Twin Study.Treating the metabolic syndrome: acetyl-CoA carboxylase inhibition.Narciclasine attenuates diet-induced obesity by promoting oxidative metabolism in skeletal muscle.Accurate label-free reaction kinetics determination using initial rate heat measurements.IL-7-Induced Glycerol Transport and TAG Synthesis Promotes Memory CD8+ T Cell Longevity.Multidisciplinary pharmacotherapeutic options for nonalcoholic Fatty liver disease.
P2860
Q21143880-1DC9D754-5E5B-4034-854A-BFD0DFD197E1Q24336781-4B3EFBAF-DFE6-4F2B-A17F-B67415FA1D74Q24654991-A9D7A09E-AF94-4469-BE86-6C2DB8A772ABQ24658124-C6222794-25BE-47AF-88E6-AB9C5CE9AC4FQ26859684-EC006E28-E8A3-4CC3-8AA5-2DF47175AB46Q26995817-EA69D0AC-FC48-43BA-90F9-AF8A1C56485EQ27000805-631959C7-AE4E-4E35-B236-9F8A833931D1Q28067324-5345858B-1928-4719-BEAE-8D2BDB230881Q28070329-AF0A3631-0CD5-4A21-85FD-C741FFBF6C04Q28116233-C2B3BDF4-AAB5-4DA7-B757-807F0813D0E8Q28483629-418A9A58-48C0-45E0-9DD8-9AFA1029531EQ28545148-C2BCAE98-5AC4-43B8-80EF-66F5EC0AB74BQ28578504-9DBE75DB-BE98-4B9E-B3DF-236D1C22D977Q28594538-46B04845-0C55-4DC6-91A1-A67238B243A7Q33461026-543EA037-49F5-4ABC-B553-886FA4D202F7Q33637226-A1092883-C681-479F-949B-A32C6756B6B3Q33675926-BF16B2EC-028F-4E7C-8E5B-4F3E0791ECB3Q33867059-81FEBF2B-EE19-4E4A-B968-86DE852F1C31Q34022351-FBA84B11-3A3A-4600-BFD4-CE5C5F833FDFQ34163854-918F8929-5985-4A00-B1C5-055ADE19292AQ34181302-AC324945-CCC3-43DB-8698-3C1BAE9295BCQ34547374-D22DC409-3A80-466B-8E1D-9E490D942400Q34620531-027DC072-14AA-43DD-B943-A3285A834FB7Q34621750-F74B6CE6-D541-41E3-B029-3C720F0AE639Q34789296-DD40B254-F9F0-4470-8E8F-82A71CD728ECQ34834899-7CA532D4-6F3E-4653-9A59-022EB6898F3CQ34955865-5F7A7075-BD77-4A7E-9A9A-6BE72BBA4D0DQ34985009-D46E4C37-8D63-43FA-AF97-8E3D1829F97DQ35060670-D9B2890C-6294-49C5-BCD6-44A9D5675DEDQ35125585-FECC4293-2CD6-4480-8F15-861ECB461776Q35138738-97706C3C-6E0A-4B14-835E-FC0DC789A8CBQ35182450-B39C224E-04F1-4FE5-BA92-20488E8F8C1CQ35575013-726862A9-DE20-43E1-8262-46814C685975Q35719541-34609997-25BC-401F-A5D4-386A352BC5A2Q35837947-B89E6274-2EC3-4289-BBD7-E87EE098C563Q36150834-08D41E58-FC6D-4B0B-A311-D0BBEB15C873Q36282422-C0D558B2-3177-40A6-88DE-34263379CFC5Q36285909-32C78AD9-FFB5-4F77-9565-D49AEBD1DD34Q36439775-9F541CAD-47F0-4833-B075-B02CC62F4967Q36470320-332019AC-4FAB-428E-B0B9-8B86DE7D5B49
P2860
Lipid metabolic enzymes: emerging drug targets for the treatment of obesity.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
2004年论文
@zh
2004年论文
@zh-cn
name
Lipid metabolic enzymes: emerging drug targets for the treatment of obesity.
@ast
Lipid metabolic enzymes: emerging drug targets for the treatment of obesity.
@en
type
label
Lipid metabolic enzymes: emerging drug targets for the treatment of obesity.
@ast
Lipid metabolic enzymes: emerging drug targets for the treatment of obesity.
@en
prefLabel
Lipid metabolic enzymes: emerging drug targets for the treatment of obesity.
@ast
Lipid metabolic enzymes: emerging drug targets for the treatment of obesity.
@en
P2860
P356
P1476
Lipid metabolic enzymes: emerging drug targets for the treatment of obesity.
@en
P2093
Yuguang Shi
P2860
P2888
P304
P356
10.1038/NRD1469
P577
2004-08-01T00:00:00Z
P5875
P6179
1024601516